Clinical trial
Impact of Body Composition, Sarcopenia, Myosteatosis, and Nutritional Status on Recurrence and Progression in Patients With Non-Muscle-Invasive Bladder Cancer: A Prospective Observational Study
NCT07285408 is registered in ClinicalTrials.gov with General Hospital Sveti Duh as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Impact of Body Composition, Sarcopenia, Myosteatosis, and Nutritional Status on Recurrence and Progression in Patients With Non-Muscle-Invasive Bladder Cancer: A Prospective Observational Study
- Lead sponsor
- General Hospital Sveti Duh
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- March 2, 2026
- Completion date
- July 9, 2029
- Enrollment
- 150 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
bladder cancer cell transitional